These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37567111)

  • 21. Pre-onset sub-threshold psychotic symptoms and cortical organization in the first episode of psychosis.
    Rosengard RJ; Makowski C; Chakravarty M; Malla AK; Joober R; Shah JL; Lepage M
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109879. PubMed ID: 32004638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive Impairments in Drug-Naive Patients With First-Episode Negative Symptom-Dominant Psychosis.
    Zhang T; Wei Y; Tang X; Cui H; Hu Y; Xu L; Liu H; Wang Z; Chen T; Hu Q; Li C; Wang J
    JAMA Netw Open; 2024 Jun; 7(6):e2415110. PubMed ID: 38842809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterising cognitive heterogeneity in individuals at clinical high-risk for psychosis: a cluster analysis with clinical and functional outcome prediction.
    Haining K; Gajwani R; Gross J; Gumley AI; Ince RAA; Lawrie SM; Schultze-Lutter F; Schwannauer M; Uhlhaas PJ
    Eur Arch Psychiatry Clin Neurosci; 2022 Apr; 272(3):437-448. PubMed ID: 34401957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive impairment in early stages of psychosis.
    Corral S; Gaspar PA; Castillo-Passi RI; Mayol Troncoso R; Mundt AP; Ignatyev Y; Nieto RR; Figueroa-Muñoz A
    Schizophr Res Cogn; 2024 Jun; 36():100302. PubMed ID: 38323136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Basic symptoms and neurocognition: preliminary comparison of first-episode psychosis vs multi-episode long-term illness].
    Savoja V; Carzedda F; Falcone I; De Carolis A; Comparelli A; Nicolò G; Kotzalidis GD; Emili E; Comazzetto C; Angelone M; Del Casale A; Ducci G; Tatarelli R; Girardi P
    Riv Psichiatr; 2013; 48(4):328-34. PubMed ID: 24056832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal change in neurocognition and its relation to symptomatic and functional changes over 2years in individuals at clinical high-risk for psychosis.
    Shin YS; Kim SY; Lee TY; Hur JW; Shin NY; Kim SN; Shin MS; Kwon JS
    Schizophr Res; 2016 Jul; 174(1-3):50-57. PubMed ID: 27068568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperprolactinemia and insulin resistance in drug naive patients with early onset first episode psychosis.
    Petruzzelli MG; Margari M; Peschechera A; de Giambattista C; De Giacomo A; Matera E; Margari F
    BMC Psychiatry; 2018 Aug; 18(1):246. PubMed ID: 30068291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort.
    Piskulic D; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
    Schizophr Res; 2016 Mar; 171(1-3):176-81. PubMed ID: 26785807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired facial emotion recognition in individuals at ultra-high risk for psychosis and with first-episode schizophrenia, and their associations with neurocognitive deficits and self-reported schizotypy.
    Lee SY; Bang M; Kim KR; Lee MK; Park JY; Song YY; Kang JI; Lee E; An SK
    Schizophr Res; 2015 Jun; 165(1):60-5. PubMed ID: 25864951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurocognition in the extended psychosis phenotype: performance of a community sample of adolescents with psychotic symptoms on the MATRICS neurocognitive battery.
    Kelleher I; Clarke MC; Rawdon C; Murphy J; Cannon M
    Schizophr Bull; 2013 Sep; 39(5):1018-26. PubMed ID: 22927672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Social cognition in clinical "at risk" for psychosis and first episode psychosis populations.
    Thompson A; Papas A; Bartholomeusz C; Allott K; Amminger GP; Nelson B; Wood S; Yung A
    Schizophr Res; 2012 Nov; 141(2-3):204-9. PubMed ID: 22959742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EEG microstate D as psychosis-specific correlate in adolescents and young adults with clinical high risk for psychosis and first-episode psychosis.
    Liebrand M; Katsarakis A; Josi J; Diezig S; Michel C; Schultze-Lutter F; Rochas V; Mancini V; Kaess M; Hubl D; Koenig T; Kindler J
    Schizophr Res; 2024 Feb; 264():49-57. PubMed ID: 38096659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of cognitive functions between first-episode schizophrenia patients, their unaffected siblings and individuals at clinical high-risk for psychosis.
    Chu AOK; Chang WC; Chan SKW; Lee EHM; Hui CLM; Chen EYH
    Psychol Med; 2019 Aug; 49(11):1929-1936. PubMed ID: 30226125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The magnitude and variability of neurocognitive performance in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies.
    Catalan A; McCutcheon RA; Aymerich C; Pedruzo B; Radua J; Rodríguez V; Salazar de Pablo G; Pacho M; Pérez JL; Solmi M; McGuire P; Giuliano AJ; Stone WS; Murray RM; Gonzalez-Torres MA; Fusar-Poli P
    Transl Psychiatry; 2024 Jan; 14(1):15. PubMed ID: 38191534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis.
    Catalan A; Salazar de Pablo G; Aymerich C; Damiani S; Sordi V; Radua J; Oliver D; McGuire P; Giuliano AJ; Stone WS; Fusar-Poli P
    JAMA Psychiatry; 2021 Jun; 78(8):859-67. PubMed ID: 34132736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: a meta-analysis.
    De Herdt A; Wampers M; Vancampfort D; De Hert M; Vanhees L; Demunter H; Van Bouwel L; Brunner E; Probst M
    Schizophr Res; 2013 Sep; 149(1-3):48-55. PubMed ID: 23830855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurocognitive and neuroanatomical maturation in the clinical high-risk states for psychosis: A pattern recognition study.
    Kambeitz-Ilankovic L; Haas SS; Meisenzahl E; Dwyer DB; Weiske J; Peters H; Möller HJ; Falkai P; Koutsouleris N
    Neuroimage Clin; 2019; 21():101624. PubMed ID: 30528960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Faux pas recognition performance in a help-seeking population at clinical high risk of psychosis.
    Zhang T; Yi Z; Li H; Cui H; Tang Y; Lu X; Xu L; Qian Z; Zhu Y; Jiang L; Chow A; Li C; Jiang K; Xiao Z; Wang J
    Eur Arch Psychiatry Clin Neurosci; 2016 Feb; 266(1):71-8. PubMed ID: 26189033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-defining Memories Predict Engagement in Structured Activity in First Episode Psychosis, Independent of Neurocognition and Metacognition.
    Wright AC; Davies G; Fowler D; Greenwood KE
    Schizophr Bull; 2019 Sep; 45(5):1081-1091. PubMed ID: 30388257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.